-
Analyst Opinions
Cocktail Culture – Industry Insights, Consumer Drivers, Brand Challenges and Innovation Landscape
Cocktail Culture Industry Report Overview The cocktail culture is a historic trend that has undergone several movements over the decades. In the 21st century, it has benefited from the craft alcohol movement and demand for premium experiences.  In 2024, cocktail culture has been influenced by relatively recent developments such as the craft craze, COVID's elevation of home-based indulgence and entertaining, increased RTD product diversity and sophistication, and the emergence of a more experiential-focused Gen Z consumer base. The ‘Cocktail Culture...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Shylicine in Diarrhea
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Shylicine in Diarrhea report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Shylicine in Diarrhea Drug Details: Shylicine is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PVX-410 in Multiple Myeloma (Kahler Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PVX-410 in Multiple Myeloma (Kahler Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PVX-410 in Multiple Myeloma (Kahler Disease) Drug Details: PVX-410 is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PVX-410 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PVX-410 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PVX-410 in Triple-Negative Breast Cancer (TNBC) Drug Details: PVX-410 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TP-102 in Diabetic Foot Ulcers
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TP-102 in Diabetic Foot Ulcers report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TP-102 in Diabetic Foot Ulcers Drug Details: TP-102 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vrelysin in Vancomycin-Resistant Enterococcus faecium Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vrelysin in Vancomycin-Resistant Enterococcus faecium Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vrelysin in Vancomycin-Resistant Enterococcus faecium Infections Drug Details: Vrelysin is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ShigActive in Bacillary Dysentery (Shigellosis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ShigActive in Bacillary Dysentery (Shigellosis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ShigActive in Bacillary Dysentery (Shigellosis)Drug Details:ShigActive is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Shylicine in Diarrhea
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Shylicine in Diarrhea report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Shylicine in Diarrhea Drug Details:Shylicine is under development for the treatment of microvillus inclusion...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MBP-134 in Ebolavirus Infections (Ebola Hemorrhagic Fever)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MBP-134 in Ebolavirus Infections (Ebola Hemorrhagic Fever) Drug Details: MBP-134 is under development for...